NCOA3 and gastric cancer: As shown in Fig. 5A, immunofluorescence assay indicated that knocking down AIB1 expression in gastric cancer cells substantially increased the expression of epithelial cell marker E-cadherin and reduced the expression of mesenchymal marker vimentin.